CAS Number 2381089-83-2 Molecular Formula C221H342N46O68 Molecular Weight 4731.4 g/mol Half-Life ~6 days (research reports) Sources & References Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial Jastreboff AM, et al
However, like any medication, GLP-1 medications can sometimes cause side effects that may impact individuals' experiences with treatment
Implement stress-reduction techniques such as meditation, yoga, deep breathing exercises, or counseling
DiStefano published research on the direct-to-consumer compounded GLP-1 Market in Colorado earlier this year
While GLP-1 drugs promote fat loss, rapid weight reduction can lead to 1525% lean muscle mass loss
CBO expects the above-noted cost per user to go down as more competitors enter the market (though CBO notes that brand prices may not drop if the drugs get better as manufacturers compete on quality as well as price), more generic alternatives appear, more people use AOMs and for longer periods of time, as well as if beneficiaries who were already on AOMs prior to joining Medicare continued their treatment